NCT00140153View on ClinicalTrials.gov

Testosterone in Female Hypoactive Sexual Desire Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions
Hypoactive Sexual Desire Disorder
Interventions
DRUG

testosterone gel (Androgel)

Trial Locations (1)

Unknown

Beersheva Mental Health Center, Beersheva

All Listed Sponsors
lead

Beersheva Mental Health Center

OTHER_GOV

NCT00140153 - Testosterone in Female Hypoactive Sexual Desire Disorder | Biotech Hunter | Biotech Hunter